Solcoderm

Solcoderm is for external use only; The procedure must be carried out by a doctor or qualified medical personnel under the supervision of a doctor.

Before the procedure, the area of ​​the affected skin area is treated with ethyl alcohol or ether. Solcoderm applied directly to the affected skin. For the application of the drug on the skin using a special plastic applicator with sharp and blunt ends, available in the package. The sharp edge is mainly used to apply the drug to small areas of affected skin; blunt end is used to handle extensive lesions.

As an alternative method of applying the drug is used enclosed glass capillary. Combined skin lesions of 2-3 cm 2 can also be treated with a glass capillary. To fill the glass capillary with the preparation, it is necessary to immerse it in a solution of Solcoderm for several minutes. Special care should be taken when applying, avoiding the application of too large volumes of Solcoderm solution and damage to the deep layers of tissue. It is necessary to apply as much of the solution as it absorbs the tissue of the affected skin.

Solcoderm gently applied to the affected skin with a plastic applicator or a glass capillary and then spread over the surface of the selected skin with light pressure using a plastic applicator until the solution completely penetrates the fabric. Over the next 3-5 minutes, it is necessary to carefully observe the changes occurring in the treated area: skin discoloration occurs with the appearance of a characteristic pale grayish or yellowish hue. The procedure should be repeated until the above mentioned discoloration of the skin occurs.

When treating keratinized warts, the top layer of the stratum corneum should be removed first.

The affected skin areas with a diameter of more than 10 mm are treated with Solcoderm only if it is determined that only the top layer of the skin is pathologically modified.

In the presence of numerous lesions of the skin, treatment with Solcoderm should be carried out in several stages, with an interval of approximately 4 weeks. During each procedure no more than 2-3 lesions can be treated with a total area of ​​no more than 2-3 cm 2.

Within a few days after the procedure, the treated area of ​​the skin becomes dark brown and dries to form a scab. In the case of unsatisfactory mummification of the diseased tissue, a repeated procedure can be performed after several days.

In order to facilitate the fixation and mummification of pathologically modified tissues that have undergone treatment, the affected areas should be treated 2-3 times a day with a swab moistened with 70% ethanol (especially after bathing or after washing).

Do not remove the scab by scraping or using mechanical means. The eschar must disappear spontaneously, otherwise a violation of tissue healing processes and the formation of scars may occur.

Studies on the possible effects of the drug on the body of women during pregnancy and lactation have not been conducted to date. Use Solcoderm during pregnancy and lactation is possible only in cases where the potential benefits of its use outweighs the possible risk to the fetus or child.

Experimental studies on animals have shown the absence of a risk factor for the fetus.

Do not use the drug Solcoderm on inflamed skin. Special care is required when treating benign skin neoplasms with the drug Solcoderm, which were previously treated with other drugs, other methods.

After biopsy of the affected area of ​​the skin, it is recommended to wait 8-10 days before starting treatment with Solcoderm solution. In the treatment of affected skin areas located near the mucous membranes, including around the eyes, special precautions should be taken. If Solcoderm solution is accidentally applied to healthy skin, it should be immediately removed with a cotton swab moistened with water. If the Solcoderm solution accidentally gets into the eye, it is necessary to immediately rinse the eye with a large amount of water or with a weak alkaline solution (1% sodium bicarbonate solution). Drops of Solcoderm solution that have fallen on furniture or clothing must be washed off with water, since Solcoderm is capable of destroying the materials from which they are made.

In the event of pain at the time of application of the drug treatment should be promptly interrupted. With the appearance of pronounced local irritation and severe itching in areas of the skin adjacent to the site of application of the drug, it is recommended to use a cream containing GCS, or an ointment that has an anesthetic effect.

Before achieving complete healing of the lesion area treated by Solcoderm (approximately 2-4 months after therapy), exposure to direct sunlight and ultraviolet radiation should be avoided. For each therapeutic procedure, you must use a new ampoule, because after opening the ampoule, Solcoderm solution is chemically unstable. The opened ampoule should be stored strictly vertically by fixing it in a special slot of the contour packaging for ampoules.

Before discarding the used ampoule, wash off the rest of the solution in running water. Empty vial can be thrown into the trash.

There are no restrictions on the use of the drug Solcoderm in children older than 5 years.

Symptoms: use of the drug Solcoderm in too large doses can lead to acid burns and damage to the deeper layers of the skin.
Treatment: an ulcer resulting from an overdose is treated like a normal wound.